Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020

Colorectal cancer (CRC) is one of the most frequent cancers worldwide. Our aim was to evaluate the availability of results of interventional studies studying CRC. We searched the ClinicalTrials.gov registry for all interventional studies on CRC management in adults completed or terminated between 01...

Full description

Bibliographic Details
Main Authors: Anna Pellat, Isabelle Boutron, Philippe Ravaud
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000106/?tool=EBI
_version_ 1818495178297573376
author Anna Pellat
Isabelle Boutron
Philippe Ravaud
author_facet Anna Pellat
Isabelle Boutron
Philippe Ravaud
author_sort Anna Pellat
collection DOAJ
description Colorectal cancer (CRC) is one of the most frequent cancers worldwide. Our aim was to evaluate the availability of results of interventional studies studying CRC. We searched the ClinicalTrials.gov registry for all interventional studies on CRC management in adults completed or terminated between 01/01/2013 and 01/01/2020. To identify results, we searched for results posted on the ClinicalTrials.gov registry and/or published in a full-text article. Our primary outcome was the proportion of CRC interventional studies with available results (i.e. posted on the ClinicalTrials.gov registry and/or published in a full-text article). Secondary outcomes were 1) median time between primary completion and earliest date of results availability, 2) the cumulative percentage of interventional studies with results available over time 3) the cumulative percentage of interventional studies with results posted on the ClinicalTrials.gov registry over time and 4) the percentage of results available in open access. We identified 763 eligible interventional studies in ClinicalTrials.gov, which included 679 198 patients. Of these, 286 (37%) trials, including 270 845 (40%) patients, did not have any results available. Median time for results availability was 32.6 months (IQ 16.1-unreached). The cumulative percentage of interventional studies with available results was 17% at 12 months, 39% at 24 months and 55% at 36 months. Results were more likely available for trials that were randomized, completed, had one trial site in the United States, and with mixed funding. The cumulative percentage of interventional studies with results posted on ClinicalTrials.gov was 2% at 12 months. Results were available in open access for 420 (420/477 = 88%) trials. Our results highlight an important waste in research for interventional studies studying CRC.
first_indexed 2024-12-10T18:16:56Z
format Article
id doaj.art-f0b2d89b584947569a6b2e1b0d41d25e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T18:16:56Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f0b2d89b584947569a6b2e1b0d41d25e2022-12-22T01:38:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01174Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020Anna PellatIsabelle BoutronPhilippe RavaudColorectal cancer (CRC) is one of the most frequent cancers worldwide. Our aim was to evaluate the availability of results of interventional studies studying CRC. We searched the ClinicalTrials.gov registry for all interventional studies on CRC management in adults completed or terminated between 01/01/2013 and 01/01/2020. To identify results, we searched for results posted on the ClinicalTrials.gov registry and/or published in a full-text article. Our primary outcome was the proportion of CRC interventional studies with available results (i.e. posted on the ClinicalTrials.gov registry and/or published in a full-text article). Secondary outcomes were 1) median time between primary completion and earliest date of results availability, 2) the cumulative percentage of interventional studies with results available over time 3) the cumulative percentage of interventional studies with results posted on the ClinicalTrials.gov registry over time and 4) the percentage of results available in open access. We identified 763 eligible interventional studies in ClinicalTrials.gov, which included 679 198 patients. Of these, 286 (37%) trials, including 270 845 (40%) patients, did not have any results available. Median time for results availability was 32.6 months (IQ 16.1-unreached). The cumulative percentage of interventional studies with available results was 17% at 12 months, 39% at 24 months and 55% at 36 months. Results were more likely available for trials that were randomized, completed, had one trial site in the United States, and with mixed funding. The cumulative percentage of interventional studies with results posted on ClinicalTrials.gov was 2% at 12 months. Results were available in open access for 420 (420/477 = 88%) trials. Our results highlight an important waste in research for interventional studies studying CRC.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000106/?tool=EBI
spellingShingle Anna Pellat
Isabelle Boutron
Philippe Ravaud
Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
PLoS ONE
title Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
title_full Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
title_fullStr Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
title_full_unstemmed Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
title_short Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
title_sort availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000106/?tool=EBI
work_keys_str_mv AT annapellat availabilityofresultsofinterventionalstudiesassessingcolorectalcancerfrom2013to2020
AT isabelleboutron availabilityofresultsofinterventionalstudiesassessingcolorectalcancerfrom2013to2020
AT philipperavaud availabilityofresultsofinterventionalstudiesassessingcolorectalcancerfrom2013to2020